Trial Shows Lateral Flow Antibody Testing Could Be Used To Assess COVID-19 Vaccine Efficacy
Executive Summary
Abingdon Health has announced that a study run in conjunction with the UK Rapid Test Consortium has demonstrated that its AbC-19 test could be an effective tool for testing vaccine efficacy.
You may also be interested in...
Pandemic Perspectives: A Lasting Impact On Medtech, But Not Dealmaking
The COVID-19 pandemic has fundamentally changed health care and the life sciences, KPMG analyst Kristin Pothier concludes in a new report on the medtech investment outlook.
UK Consortium Given Go-Ahead For Rapid SARS-CoV-2 Antibody Test In Europe
UK-Rapid Test Consortium claims the CE marked, professional-use test is 99.4% accurate and plans to produce 500,000 tests a month from October and one million a month starting in 2021.
Snapshot: May Highlights
A selection of articles you might have missed from May 2022, including exclusive interviews, an in depth discussion about China's rise to become one of the world's leaders in R&D, and the latest Rising Leaders interviews.